Status:
UNKNOWN
Shanghai High Myopia Study for Adults
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Conditions:
High Myopia
Eligibility:
All Genders
18-100 years
Brief Summary
High myopia retinopathy has become the first cause of irreversible blindness and severe visual impairment in Chinese adults, in order to avoid the blind and visual impairment caused by high myopia ret...
Eligibility Criteria
Inclusion
- ≥18 years old; spherical equivalent refraction ≤-6.00D;
Exclusion
- a history of ocular or systemic diseases including congenital cataract and glaucoma; previous intraocular or refractive surgery;other evidence of retinal pathology
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03446300
Start Date
January 1 2016
End Date
December 31 2020
Last Update
February 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Eye Disease Prevention & Treatment Center
Shanghai, Shanghai Municipality, China, 200040